Titan Pharmaceuticals
TTNP
#11031
Rank
โ‚น0.57 B
Marketcap
โ‚น432.93
Share price
-3.76%
Change (1 day)
23.00%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น412.26. In 2023 the company made an earnings per share (EPS) of -โ‚น695.87 an increase over its 2022 EPS that were of -โ‚น1,426.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น695.87-51.22%
2022-โ‚น1,426-15.61%
2021-โ‚น1,690-81.37%
2020-โ‚น9,072-77.52%
2019-โ‚น40,363-56.32%
2018-โ‚น92,408-59.51%
2017-โ‚น2,28,249-371.81%
2016โ‚น83,973-144.35%
2015-โ‚น1,89,324300%
2014-โ‚น47,331-121.54%
2013โ‚น2,19,751-151.38%
2012-โ‚น4,27,670-11.54%
2011-โ‚น4,83,453188.89%
2010-โ‚น1,67,349-10%
2009-โ‚น1,85,943
2007-โ‚น7,62,368-2.38%
2006-โ‚น7,80,963-39.13%
2005-โ‚น12,83,010-16.87%
2004-โ‚น15,43,331-22.43%
2003-โ‚น19,89,5954.9%
2002-โ‚น18,96,62461.9%
2001-โ‚น11,71,444-13.7%
2000-โ‚น13,57,38765.01%
1999-โ‚น8,22,623-35.87%
1998-โ‚น12,82,791-1824.71%
1997โ‚น74,377-102.4%
1996-โ‚น31,05,256

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น627.75-252.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น493.03-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น434.80 5.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-โ‚น18.78-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น21.60-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.51-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA